In Vitro Toxicology Testing Market Worth $17.1 Billion by 2028 : Strategic Planning, Business Opportunity
In March 2023, Agilent Technologies, Inc. (US) acquired e-MSion (US). Through this acquisition, Agilent will integrate the e-MSion's ExD cell into its portfolio of advanced workflows, instruments, and analytical solutions for biotherapeutic characterization and development.
View full press release